Literature DB >> 2582118

Tumour markers in testicular cancer.

P A Light.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2582118      PMCID： PMC1289485     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  20 in total

1.  Serum ferritin as a third marker in germ cell tumours.

Authors:  A Grail; G Bates; A M Ward; W G Jones; B W Hancock
Journal:  Eur J Cancer Clin Oncol       Date:  1982-03

2.  Value of five tumor markers (AFP, CEA, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.

Authors:  J J Szymendera; J Zborzil; L Sikorowa; J A Kamińska; A Gadek
Journal:  Oncology       Date:  1981       Impact factor: 2.935

3.  Tumor markers in advanced nonseminomatous testicular cancer.

Authors:  G J Bosl; P H Lange; L E Nochomovitz; A Goldmann; E E Fraley; J Rosai; K Johnson; B J Kennedy
Journal:  Cancer       Date:  1981-02-01       Impact factor: 6.860

4.  Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.

Authors:  G J Bosl; P H Lange; E E Fraley; A Goldman; L E Nochomovitz; J Rosai; T A Waldmann; K Johnson; B J Kennedy
Journal:  Cancer       Date:  1981-01-15       Impact factor: 6.860

5.  Monoclonal antibodies to different epitopes of human alpha-fetoprotein (AFP).

Authors:  B Micheel; H Fiebach; U Karsten; A I Goussev; A K Jazova; J Kopp
Journal:  Eur J Cancer Clin Oncol       Date:  1983-09

6.  Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP.

Authors:  A Talerman; W G Haije; L Baggerman
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

7.  Marker half-life analysis as a prognostic tool in testicular cancer.

Authors:  P H Lange; N J Vogelzang; A Goldman; B J Kennedy; E E Fraley
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

8.  Biochemical markers in advanced testicular tumors: serum lactate dehydrogenase, urinary chorionic gonadotropin and total urinary estrogens.

Authors:  F E von Eyben
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

9.  Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.

Authors:  D Raghavan; M J Peckham; E Heyderman; J S Tobias; D E Austin
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

10.  Tumour-marker levels and prognosis in malignant teratoma of the testis.

Authors:  J R Germa-Lluch; R H Begent; K D Bagshawe
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.